James A. Schoeneck is President at DEPOMED INC (DEPO). They have made 13 open-market trades across 3 companies since 2011, most recently 2025-08-21.
CIK 0001420987
5 open-market purchases totalling $703K since 2011, against 8 sales. Across 5 scored buys the stock is up 12.4% at ninety days, and 9.2 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 60% | 60% |
| Avg Move | -7.2% | +0.6% | +12.4% |
| Alpha | -3.6% | +1.3% | +9.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDI | BUY | 2025-08-21 | 2025-08-25 | $2.00 | $150K | -7.0% | -9.9% | -22.1% |
| FGEN | BUY | 2025-06-30 | 2025-07-02 | $5.07 | $239K | +31.2% | +23.5% | +119.5% |
| FGEN | BUY | 2025-03-20 | 2025-03-24 | $0.35 | $105K | -18.7% | -15.3% | -40.3% |
| FGEN | SELL · 10b5-1 | 2023-06-07 | 2023-06-09 | $18.03 | $256K | -2.4% | -83.7% | -94.2% |
| FGEN | SELL | 2019-05-07 | 2019-05-09 | $47.02 | $94K | -2.8% | +7.8% | +22.0% |
| FGEN | SELL | 2019-04-08 | 2019-04-10 | $52.90 | $106K | -11.7% | -32.9% | -17.4% |
| FGEN | SELL | 2019-03-07 | 2019-03-08 | $54.68 | $198K | +1.0% | -3.0% | -29.7% |
| FGEN | SELL | 2019-02-07 | 2019-02-08 | $57.17 | $114K | -2.8% | -5.8% | -20.6% |
| FGEN | SELL | 2019-01-07 | 2019-01-09 | $45.90 | $92K | +9.8% | +21.6% | +12.3% |
| FGEN | SELL | 2018-07-03 | 2018-07-06 | $65.00 | $497K | -3.1% | -7.3% | -13.9% |
| FGEN | SELL | 2018-06-22 | 2018-06-26 | $65.00 | $283K | +7.2% | +6.3% | -2.3% |
| DEPO | SELL · 10b5-1 | 2014-12-02 | 2014-12-03 | $15.85 | $582K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL | 2014-03-14 | 2014-03-14 | $14.54 | $247K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $8.40 | $144K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2013-05-10 | 2013-05-13 | $5.11 | $128K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2011-08-23 | 2011-08-24 | $5.12 | $82K | -20.6% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.